Inhibition of MNK pathway sensitizes nasopharyngeal carcinoma to radiotherapy
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Inhibition of MNK pathway sensitizes nasopharyngeal carcinoma to radiotherapy
Authors
Keywords
-
Journal
ANTI-CANCER DRUGS
Volume -, Issue -, Pages -
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2023-09-11
DOI
10.1097/cad.0000000000001542
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Inhibition of eukaryotic initiation factor 4E by tomivosertib suppresses angiogenesis, growth and survival of glioblastoma and enhances chemotherapy’s efficacy
- (2023) Qi Zhang et al. FUNDAMENTAL & CLINICAL PHARMACOLOGY
- Inhibition of mTOR by temsirolimus overcomes radio‐resistance in nasopharyngeal carcinoma
- (2022) Shiyong Huang et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- Treatment with eFT-508 increases chemosensitivity in breast cancer cells by modulating the tumor microenvironment
- (2022) Zhao-ying Yang et al. Journal of Translational Medicine
- The Evolving Epidemiology of Nasopharyngeal Carcinoma
- (2021) Ellen T. Chang et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Inhibitory effects of Tomivosertib in acute myeloid leukemia
- (2021) Milagros Suarez et al. Oncotarget
- Update on the Development of MNK Inhibitors as Therapeutic Agents
- (2021) Weijun Xu et al. JOURNAL OF MEDICINAL CHEMISTRY
- Nasopharyngeal carcinoma: an evolving paradigm
- (2021) Kenneth C. W. Wong et al. Nature Reviews Clinical Oncology
- Suppression of oncogenic protein translation via targeting eukaryotic translation initiation factor 4E overcomes chemo-resistance in nasopharyngeal carcinoma
- (2019) Mingfang Xu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Ribavirin sensitizes nasopharyngeal carcinoma to 5-fluorouracil through suppressing 5-fluorouracil-induced ERK-dependent-eIF4E activation
- (2019) Zhihua Hu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Structure-based Design of Pyridone–Aminal eFT508 Targeting Dysregulated Translation by Selective Mitogen-activated Protein Kinase Interacting Kinases 1 and 2 (MNK1/2) Inhibition
- (2018) Siegfried H. Reich et al. JOURNAL OF MEDICINAL CHEMISTRY
- Inhibition of Mnk–eIF4E pathway sensitizes the efficacy to chemotherapy in anaplastic thyroid cancer
- (2017) Kun Hu et al. Future Oncology
- Inhibition of MNK pathways enhances cancer cell response to chemotherapy with temozolomide and targeted radionuclide therapy
- (2016) Michal Grzmil et al. CELLULAR SIGNALLING
- peIF4E as an independent prognostic factor and a potential therapeutic target in diffuse infiltrating astrocytomas
- (2016) Elena Martínez-Sáez et al. Cancer Medicine
- Mnks, eIF4E phosphorylation and cancer
- (2015) Christopher G. Proud Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- Targeting of the MNK-eIF4E axis in blast crisis chronic myeloid leukemia inhibits leukemia stem cell function
- (2013) S. Lim et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- EIF4E over-expresses and enhances cell proliferation and cell cycle progression in nasopharyngeal carcinoma
- (2012) Mengyan Wu et al. MEDICAL ONCOLOGY
- Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method
- (2010) T.-C. Chou CANCER RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now